Seoul High Court rejected injunction ruling on 45 items

Published: 2002-12-09 07:00:00

Updated: 2002-12-09 07:00:00

Pharmaceutical business sources say that the administrative litigation involving the reduction of reimbursement price of insurance drugs will take a new turning point, as Seoul High Court acknowledged on December 3rd the complaints of the health ministry on 23 items (six firms) having injunction ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK